These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 10946807
41. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'? Doe JY, Funk M, Mengel M, Doehring E, Ehrich JH. Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742 [Abstract] [Full Text] [Related]
42. Steroid effects on minimal lesion nephrotic syndrome with and without immune deposits. Kim PK, Kim NA, Kim KS, Choi IJ. Int J Pediatr Nephrol; 1982 Dec; 3(4):257-61. PubMed ID: 7166452 [Abstract] [Full Text] [Related]
43. Rheumatoid factors in patients with minimal change nephrotic syndrome. Endoh M, Miyazaki M, Suga T, Miura M, Nomoto Y, Sakai H. Clin Nephrol; 1991 Mar; 35(3):93-7. PubMed ID: 2032402 [Abstract] [Full Text] [Related]
44. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses. Tse KC, Lam MF, Yip PS, Li FK, Choy BY, Lai KN, Chan TM. Nephrol Dial Transplant; 2003 Jul; 18(7):1316-20. PubMed ID: 12808168 [Abstract] [Full Text] [Related]
45. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Kyrieleis HA, Levtchenko EN, Wetzels JF. Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840 [Abstract] [Full Text] [Related]
47. Human glomerular growth during childhood: a morphometric study. Akaoka K, White RH, Raafat F. J Pathol; 1994 Jul; 173(3):261-8. PubMed ID: 7931846 [Abstract] [Full Text] [Related]
48. Resolution of IgM nephropathy after rituximab treatment. Betjes MG, Roodnat JI. Am J Kidney Dis; 2009 Jun; 53(6):1059-62. PubMed ID: 19084309 [Abstract] [Full Text] [Related]
49. The relation of IgM deposition to clinical parameters and histomorphometry in childhood mesangial proliferative glomerulonephritis. Kasap B, Türkmen M, Sarioğlu S, Sis B, Soylu A, Kavukçu S. Pathol Res Pract; 2008 Jun; 204(3):149-53. PubMed ID: 18093746 [Abstract] [Full Text] [Related]
50. Mesangial myofibroblastic transformation in steroid-dependent minimal change nephrotic syndrome. Naruse K, Fujieda M, Miyazaki E, Hayashi Y, Toi M, Kuroda N, Hiroi M, Kurashige T, Enzan H. Med Electron Microsc; 2000 Jun; 33(2):102-7. PubMed ID: 11810466 [Abstract] [Full Text] [Related]
51. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains. Wijnhoven TJ, Geelen JM, Bakker M, Lensen JF, Rops AL, Kramer AB, Navis G, van den Hoven MJ, van der Vlag J, Berden JH, Wetzels JF, van den Heuvel LP, Monnens LA, van Kuppevelt TH. Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541 [Abstract] [Full Text] [Related]
52. Does electron microscopy change the view of the diagnosis of IgA nephropathy? Maixnerová D, Honsová E, Merta M, Reiterová J, Rysavá R, Tesar V, Obeidová H, Motan J. Prague Med Rep; 2005 Oct; 106(3):283-90. PubMed ID: 16463586 [Abstract] [Full Text] [Related]
53. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Ji-Yun Y, Melvin T, Sibley R, Michael AF. Kidney Int; 1984 Jan; 25(1):100-6. PubMed ID: 6727121 [Abstract] [Full Text] [Related]
54. Clinical and morphological (including morphometric) aspects of minimal change disease and mesangial glomerulonephritis with unfavourable course in children. Salwa-Zurawska W, Bortkiewicz E, Woźniak A, Kaczmarek E, Maciejewski J. Pol J Pathol; 1999 Jan; 50(3):163-75. PubMed ID: 10624118 [Abstract] [Full Text] [Related]
55. Depression of endostreptosin, streptolysin O and streptozyme antibodies in patients with idiopathic nephrosis with and without a nephrotic syndrome. Lange K, Ahmed U, Seligson G, Grover A. Clin Nephrol; 1981 Jun; 15(6):279-85. PubMed ID: 7249425 [Abstract] [Full Text] [Related]
56. Inhibitory factors of lymphocyte transformation in sera from patients with minimal change nephrotic syndrome. Beale MG, Hoffsten PE, Robson AM, MacDermott RP. Clin Nephrol; 1980 Jun; 13(6):271-6. PubMed ID: 6447569 [Abstract] [Full Text] [Related]
57. Immunological profile in children with minimal change nephrotic syndrome. Gupta S, Yuceoglu AM. Acta Paediatr Scand; 1985 Sep; 74(5):726-32. PubMed ID: 2931943 [Abstract] [Full Text] [Related]
59. B lymphocyte subset patterns and their significance in idiopathic glomerulonephritis. Tani Y, Kida H, Abe T, Tomosugi N, Saito Y, Asamoto T, Hattori N. Clin Exp Immunol; 1982 Apr; 48(1):201-4. PubMed ID: 6979448 [Abstract] [Full Text] [Related]
60. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M. Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]